Pramiracetam Reference

Plain English

What it is

Pramiracetam is a lab-made brain compound in the 'racetam' family, closely related to piracetam. It is not approved by the FDA in the United States, and racetams like it are not legal dietary supplements here, so in the US it is sold as a research chemical. It is sold as a prescription medicine in Italy and parts of Eastern Europe (brand name Pramistar) for memory and attention problems in older people with certain types of dementia.

What people use it for

In nootropic (so-called 'smart drug') communities, people use it to try to boost memory and recall, and many describe it as feeling stronger than piracetam. These are personal reports, not proven medical results.

What the science shows

The human studies are small and limited, and even how it works in the brain is not fully settled. Lab research suggests it can raise the brain's uptake of choline, a building block of a memory-related brain chemical, but its benefits for healthy people remain largely unproven.

The catch

Because it is not FDA-approved and is not a legal US supplement, product quality and purity are not guaranteed, and the cognitive claims rest on weak evidence. For research and educational purposes only. Not medical advice.

Reference summary

Smaller Italian clinical literature; reportedly higher choline-system activity than other racetams.

Regulatory and posture

Categories

Nootropic, Cognitive

Aliases

Pramistar, CI-879

Evidence posture

human - Not FDA-approved in the US. Italian non-US approval. Community framing extrapolates beyond the approved cognitive-impairment indication.

Regulatory status

No FDA-approved pramiracetam drug label. Approved in Italy for memory / cognitive impairment under the brand Pramistar.

Content review status

research reference